Loading...

PE anti-mouse TER-119/Erythroid Cells Antibody

Pricing & Availability
Clone
TER-119 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-76
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
TER-119_PE_122107
C57BL/6 bone marrow cells stained with TER-119 PE and anti-mouse CD45 APC
  • TER-119_PE_122107
    C57BL/6 bone marrow cells stained with TER-119 PE and anti-mouse CD45 APC
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
116207 50 µg 59€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
116208 200 µg 153€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The TER-119 antigen is a 52 kD glycophorin A-associated protein, also known as Ly-76. TER-119 is an erythroid-specific antigen expressed on early proerythroblasts to mature erythrocytes, but not on erythroid colony-forming cells (BFU-E, blast-forming unit erythroid, or CFU-E, colony-forming unit erythroid).

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Day-14 fetal liver cells from a C57BL/6 mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1, complement-mediated cytotoxicity3, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References

(PubMed link indicates BioLegend citation)
  1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
  2. Vannucchi AM, et al. 2000. Blood 95:2559.
  3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
  4. Grisendi S, et al. 2005. Nature 437:147. (FC)
  5. Bourdeau A, et al. 2007. Blood 109:4220.
  6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
  7. Heuser M, et al. 2007. Blood 110:1639. (FC)
  8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed
Product Citations
  1. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  4. Wang MX, et al. 2022. FASEB J. 36:e22562. PubMed
  5. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  6. Verhoeven J, et al. 2022. Methods Mol Biol. 2572:45. PubMed
  7. Chand M, et al. 2022. Front Cell Infect Microbiol. 12:1039197. PubMed
  8. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  9. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  10. White Z, et al. 2022. Blood Cells Mol Dis. 97:102688. PubMed
  11. Palam LR, et al. 2023. JCI Insight. 8:. PubMed
  12. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  13. Sun D, et al. 2021. Cell Stem Cell. . PubMed
  14. Xhima K, et al. 2020. Sci Adv. 6:eaax6646. PubMed
  15. Hodzic D, et al. 2022. PLoS Biol. 20:e3001811. PubMed
  16. Wong J, et al. 2015. Elife. 3: 07839. PubMed
  17. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  18. Silva C, et al. 2019. Cell Physiol Biochem. 52:503. PubMed
  19. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  20. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  21. Toda S, et al. 2014. Blood. 123:3963. PubMed
  22. Chao CC, et al. 2020. Cell. 179(7):1483-1498.e22.. PubMed
  23. Li J, et al. 2019. JCI Insight. 5. PubMed
  24. Duek A, et al. 2014. Blood. 123:3943. PubMed
  25. Zhou Y, et al. 2022. Nat Commun. 13:2906. PubMed
  26. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  27. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  28. Lassen K, et al. 2014. Proc Natl Acad Sci U S A. 111:7741. PubMed
  29. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  30. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  31. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  32. Beyaz S, et al. 2016. Nature. 531:53-58. PubMed
  33. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  34. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  35. Hsieh W, et al. 2015. Gut. 64:312. PubMed
  36. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  37. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  38. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  39. Hirukawa A, et al. 2019. Cell Rep. 29:249. PubMed
  40. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  41. Cho K, et al. 2021. iScience. 24:103117. PubMed
  42. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  43. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  44. Taves MD, et al. 2019. Cell Rep. 26:3629. PubMed
  45. Shamaladevi N, et al. 2009. Cancer Res. 69:8265. PubMed
  46. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  47. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  48. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  49. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  50. Mana MD, et al. 2021. Cell Reports. 35(10):109212. PubMed
  51. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  52. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  53. Rotzius P, et al. 2010. Am J Pathol. 177:493. PubMed
  54. Gonzalez-Ibanez AM, et al. 2020. Front Cell Dev Biol. 8:592035. PubMed
  55. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  56. Morioka S, et al. 2012. Blood. 120:3846. PubMed
  57. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  58. Yoshinaga M, et al. 2022. Nat Commun. 13:6435. PubMed
  59. Darlyuk-Saadon I, et al. 2021. FEBS J. 288:3978. PubMed
  60. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  61. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  62. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  63. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  64. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
  65. Jia W, et al. 2020. Theranostics. 10:6886. PubMed
  66. Kumari R, et al. 2022. Int J Mol Sci. 23:. PubMed
RRID
AB_313708 (BioLegend Cat. No. 116207)
AB_313708 (BioLegend Cat. No. 116208)

Antigen Details

Structure
Associated with glycophorin A, 52 kD
Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type
Erythrocytes
Biology Area
Immunology
Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID
104231 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
TER-119
Specificity Alt (DOES NOT SHOW ON TDS):
TER-119
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about TER-119 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All TER-119 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse TER-119/Erythroid Cells TER-119 FC
Biotin anti-mouse TER-119/Erythroid Cells TER-119 FC
FITC anti-mouse TER-119/Erythroid Cells TER-119 FC
PE anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine5 anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB
Alexa Fluor® 488 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 647 anti-mouse TER-119/Erythroid Cells TER-119 FC
Alexa Fluor® 700 anti-mouse TER-119/Erythroid Cells TER-119 FC
PE/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Cyanine7 anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP anti-mouse TER-119/Erythroid Cells TER-119 FC
PerCP/Cyanine5.5 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 421™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Pacific Blue™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 650™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 510™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 605™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Purified anti-mouse TER-119/Erythroid Cells (Maxpar® Ready) TER-119 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse TER-119/Erythroid Cells TER-119 FC
Brilliant Violet 785™ anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-A0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
APC/Fire™ 750 anti-mouse TER-119/Erythroid Cells TER-119 FC
TotalSeq™-B0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
TotalSeq™-C0122 anti-mouse TER-119/Erythroid Cells TER-119 PG
Ultra-LEAF™ Purified anti-mouse TER-119/Erythroid Cells TER-119 FC,IHC-F,IHC-P,IP,WB,CMCD
Spark Blue™ 550 anti-mouse TER-119/Erythroid Cells TER-119 FC
APC/Fire™ 810 anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark NIR™ 685 anti-mouse TER-119/Erythroid Cells Antibody TER-119 FC
Brilliant Violet 711™ anti-mouse TER-119/Erythroid Cells TER-119 FC
Spark Red™ 718 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Spark Blue™ 574 anti-mouse TER-119/Erythroid Cells (Flexi-Fluor™) TER-119 FC
Go To Top Version: 2    Revision Date: 12.04.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account